Jeeva Clinical Trials Inc.
PrivateLast Round
Grant
Jun 27, 2023
Total Funding Raised
$175,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jeeva Clinical Trials Inc. operates in Healthcare & Life Sciences and is based in Manassas, Virginia. Its latest recorded funding round was a Grant round in June 2023.
Jeeva Clinical Trials Inc. is a healthtech company that provides a unified, AI-powered software-as-a-service (SaaS) platform to streamline decentralized and hybrid clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Vertical SaaS, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jeeva Clinical Trials Inc. Comparables
Compare Jeeva Clinical Trials Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ClinCapture, Inc. | 85% | |
| Medrio | 82% | |
| OpenClinica | 81% |
For institutional investors. Book with your work email.
Jeeva Clinical Trials Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 27, 2023 | ||||
| VC Round | Aug 31, 2022 | ||||
| Grant | Jan 14, 2022 | ||||
| Seed | Jan 8, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Jeeva Clinical Trials Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prince William County Department of Economic Development and Tourism | Grant |
| Virginia Venture Partners | VC Round |
| Virginia Innovation Partnership Corporation | Grant, Seed |
| Virginia Venture Partners | VC Round |
| NSF I-Corps Program | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 9, 2026
Added Bethesdadetailers as a new customer.
- May 9, 2026
Added Lake Geneva Pickleball, LLC. as a customer.
For institutional investors. Book with your work email.
Jeeva Clinical Trials Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jeeva Clinical Trials Inc.'s valuation, stock price, and market status.
Is Jeeva Clinical Trials Inc. a public or private company?
Jeeva Clinical Trials Inc. is a private company.
What is the current stock price of Jeeva Clinical Trials Inc.?
Jeeva Clinical Trials Inc. is a private company, so its shares have no public market price. Caplight tracks Jeeva Clinical Trials Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jeeva Clinical Trials Inc. worth (valuation)?
Valuation information for Jeeva Clinical Trials Inc. is not publicly available.
Can I buy Jeeva Clinical Trials Inc. stock?
Jeeva Clinical Trials Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jeeva Clinical Trials Inc.'s last funding round?
Jeeva Clinical Trials Inc.'s most recent funding round was Grant on June 27, 2023.
Who are the main investors in Jeeva Clinical Trials Inc.?
Key investors in Jeeva Clinical Trials Inc. include Prince William County Department of Economic Development and Tourism, Virginia Venture Partners, Virginia Innovation Partnership Corporation.
Will Jeeva Clinical Trials Inc. IPO soon?
No public IPO plans have been announced for Jeeva Clinical Trials Inc..
How can I track Jeeva Clinical Trials Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Jeeva Clinical Trials Inc.'s shares on secondary markets.